CCM
AGN

Cadian Capital Management’s Allergan plc AGN Stock Holding History

Cadian Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-175,000
Closed -$29.4M – 109
2013
Q4 		$29.4M Buy
175,000
+15,000
+9% +$2.34M 0.76% 31
2013
Q3 		$23M Buy
+160,000
New +$21.3M 0.68% 36

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Cadian Capital Management's AGN Position: Q1 2014 in Review

Cadian Capital Management sold out of Allergan plc (AGN) in Q1 2014, closing a stake of 175,000 shares — an estimated $29.4M sold.

Cadian Capital Management first reported a position in AGN in Q3 2013 and held it in 2 quarters. The position peaked at $29.4M in Q4 2013. 628 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

  • Cadian Capital Management reported no remaining Allergan plc position as of Q1 2014 after selling out during the quarter.
  • Cadian Capital Management sold 175,000 Allergan plc shares in Q1 2014, an estimated $29.4M.
  • Cadian Capital Management first reported a position in Allergan plc in Q3 2013 and held it in 2 quarters.
  • Cadian Capital Management's Allergan plc position peaked at $29.4M in Q4 2013.
  • 628 funds tracked by Wall St. Rank held Allergan plc as of Q1 2014.

Based on Cadian Capital Management's 13F filing for Q1 2014, filed 14 May 2014.